Loss of coping ability and depression have been associated with compromised AMPA receptor activation due, in part, to changes in expression of the GluA1 subunit (Duric and Duman, 2013); whereas, enhanced activation of AMPA receptors promotes an antidepressant effect (Farley et al., 2010). Here, GRIA1 is linked to depressive symptom measurement.